Antimicrobial drugs for livestock sales distribution by indication U.S. 2022

Nota: La página que ha solicitado no está en su idioma predeterminado. Usted está usando nuestra plataforma en otro idioma ahora.

This statistic depicts the domestic sales distribution of antimicrobial drugs for usage in livestock in the United States from 2009 to 2022, by indication. In 2022, 15 percent of medically important antimicrobial drug sales were used for therapeutic indications only.

Domestic sales distribution of antimicrobial drugs for use in livestock in the United States from 2009 to 2022, by indication

Characteristic	Production indications only or production/therapeutic indications	Therapeutic indications only
2022	85%	15%
2021	80%	20%
2020	81%	19%
2019*	0%	100%
2018*	0%	100%
2017*	0%	100%
2016	69%	31%
2015	71%	29%
2014	72%	28%
2013	72%	28%
2012	68%	32%
2011	70%	30%
2010	71%	29%
2009	72%	28%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

December 2023

More information

Region

United States

Survey time period

2009 to 2022

Supplementary notes

Includes antimicrobial drug applications which are approved and labeled for use in both food-producing animals (e.g., cattle and swine) and nonfood-producing animals (e.g., dogs and cats).
Includes medically important drugs only.
Production indications: e.g., increased rate of weight gain or improved feed efficiency.
Therapeutic indications: e.g., treatment, control, or prevention of a specific disease.
* The quantity reported 2017-2019 under the production indications category dropped to zero as a result of the implementation of GFI #213. Applications that were formerly in the Production category were voluntarily withdrawn. Applications that were formerly in the Production/Therapeutic Indications category had production claims eliminated and were moved to the Therapeutic Only Indications category.

Citation formats